Stanford Mussallem Center for Biodesign’s Post

I don't usually re-post the DNB//Back Bay weekly market update but wanted to reiterate one observation. The Madrigal announcement is noteworthy as it is reflective of both the challenge and promise of our biotechnology space. A disease is noted and newly described, research begins into causation as well as potential solutions, capital enters and then failures ensue and capital retreats. But the perseverance of scientists, clinicians, companies, and capital renders a solution which then becomes life changing. The time sequence is usually decades. For all we live quarter to quarter in the finance world, thank goodness that vision and strategy prevail to bring these solutions forward. https://lnkd.in/gztv5HHM

𝑷𝒖𝒃𝒍𝒊𝒄 𝑷𝒓𝒊𝒗𝒂𝒕𝒆 𝑷𝒂𝒓𝒕𝒏𝒆𝒓𝒔𝒉𝒊𝒑𝒔 – 𝒑𝒂𝒗𝒊𝒏𝒈 𝒕𝒉𝒆 𝒘𝒂𝒚 𝒇𝒐𝒓 𝒄𝒐𝒍𝒍𝒂𝒃𝒐𝒓𝒂𝒕𝒊𝒗𝒆 𝒊𝒏𝒏𝒐𝒗𝒂𝒕𝒊𝒐𝒏 🤝 On the occasion of the European Biotechnology Revue (EBR) spring issue, Julia Schaft gave an interview on the emergence and further development of public-private partnerships. Julia explains in the interview: 💡Most common barriers of industry-academia partnerships and how they can be overcome 💡How these partnerships will develop in the future 💡How these partnerships can be encouraged at an international level and 💡What can be done to advance the growth of Life Sciences hubs 👉 Read the whole article: https://bit.ly/3Turb89 Samedan Ltd; BioMed X Institute;

Just one week to go until the Life Sciences Summit! If you are attending and are interested in advancing your life sciences research with #bioinformatics, arrange to meet with Eleanore Irvine or Tom Ng at the summit! Just send them a message on LinkedIn today and they will see you next week! #lifesciences #biotech #drugdiscovery

Link to an informative write up, co authored by OMAPiX colleagues. The article provides details on identifying crucial insights using spatial multi modal analysis. OMAPIX has a team with domain expertise in ‘spatial omics' technologies scalable to support clinical decision making. With several active programs integrating these technologies with unique computation tools, we can collaborate to generate the right strategy for in depth analysis of drug MOA and disease characterization. Talkto us about how we can support your programs to advance your pipe line of assets and scale successfully to the clinic. 

Many of the biggest recent scientific breakthroughs have emerged from the field of biotechnology: invisible cochlear implants, genome-edited crops, and vaccines for once-incurable diseases. Alex Zhavoronkov will be joining a panel of experts at the Fortune Innovation Forum on May 27 to find out what more could be possible. #BiotechnologyBreakthroughs #MedicalAdvancements #FortuneInnovationForum #ExpertPanel #FutureTech

Exciting on-site visits to leading Biobanks, including Charité and the University Hospital Dresden, provided precious insights into the 'gold of the 21st century.' Rounded off the journey with a stop at the EU-OPENSCREEN compound library in Berlin. EU-OPENSCREEN integrates high-capacity screening platforms throughout Europe 🌱💼 #Biobanking #Research #CharitéBerlin #UniversityHospitalDresden #EUOPENSCREEN This hands-on experience lays a solid foundation for our crafting user-centric #WhitePapers and #ApplicationNotes tailored to our clients' needs. 💡📝 #LifeSciences #Biotech"

What happens when the world comes together to solve healthcare challenges? ◾ Alex Zhavoronkov, PhD, founder & CEO of Insilico Medicine joins a panel of experts, including 尹烨 of BGI Group and Jerry Liao, founder and CEO of WeDoctor (微医集团) for the inaugural Fortune Innovation Forum in Hong Kong on May 27 to discuss "Shaping the Next Era of Healthcare." ◾ Many of the biggest recent scientific breakthroughs have come via biotechnology: invisible cochlear implants, genome-edited crops, and vaccines for once-incurable diseases. The panel explores: What more could be possible when the world comes together to develop mutually beneficial technology?  👉 Learn more and register: https://lnkd.in/g3MrBmWj #ai #global #innovation #fortune #biotech #healthcare

🔬 Exciting Developments in #LifeScience! 🔍 Thrilled to share the latest breakthroughs shaping the future of life sciences. 🌱 From innovative research to groundbreaking discoveries, our industry is pushing boundaries and revolutionizing healthcare. 💊 🌐 Let's celebrate the dedicated scientists, researchers, and professionals driving progress in life science. 🙌 Your relentless pursuit of knowledge is transforming the way we understand and treat diseases. Together, we're building a healthier and more sustainable world. 🌍 🚀 Whether you're working in biotech, pharmaceuticals, genomics, or any other facet of life science, your contributions are making a significant impact. Share your insights and achievements below! 👇 #LifeScienceInnovation #Biotechnology #HealthcareRevolution #ResearchMatters #ScienceCommunity #Innovation #HealthTech #BiotechAdvancements #Resonacle

Had an amazing trip to the 2nd Government Biotechnology Innovation Summit. As CEO of Ora Biomedical, Inc., it was so important to learn about biotechnology as seen through the eyes of diverse stakeholders. Patients, servicemembers, farmers, regulators, and more all have an important unique perspective on what is being called the coming "Age of Biology". Longevity biotech #longbio would do well to engage these stakeholders as we continue to develop novel use cases for healthy longevity interventions. #wormbot #millionmoleculechallenge Matt Kaeberlein, Ben Blue, Brian Kennedy

Exciting news! Our CEO will be a panelist at the The Inaugural Phoenix Global Forum 2024, discussing the "Biotechnology Revolution: Advancements, Challenges, and Future Outlook" today, May 2nd, at 2:30-3:30pm MST. Join us for this crucial conversation shaping the future of healthcare! #Biotechnology #Innovation #RegenerativeMedicine #Healthcare #PhoenixGlobalForum